THE ROLE OF CYTOCHROME P450 ISOFORMS IN THE BREAST CANCER COURSE DEPENDING ON THE TUMOR MOLECULAR SUBTYPE
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-23-1-2021-g.9330Keywords:
breast cancer, cytochrome P450, estrogens, mammary adipose tissue, superoxide radicals, survivalAbstract
Aim: to investigate the levels of cytochrome P450 and its CYP 1A2, CYP 1B1 isoforms in tumor tissue and mammary adipose tissue in normal weight and overweight patients with different subtypes of breast cancer (BC). Object and methods: The surgical tissue of 73 patients with stage II (n=40) and III (n=33) BC aged 48.2 ± 10.2 years was used in the study. Luminal A breast cancer (LABC) was diagnosed in 35 patients; 38 patients had triple-negative BC (TNBC). The level of cytochrome P450 and its CYP 1A2, CYP 1B1 and CYP 19A1 isoforms in the tumor tissue and mammary adipose tissue was examined by electron paramagnetic resonance and spectrophotometrically. Enzymatic formation of estrogen adducts was determined by gas-liquid chromatography. Statistical analysis was performed using the R project (www.r-project.org). Results: The diverse levels of cytochrome P450 isoforms were determined in BC of different molecular subtypes. The levels of CYP 19A1 і CYP 1B1 isoforms in the tumor tissue of patients with TNBC were 1.8 times higher as compared to the patients with LABC. Increase in CYP19A1 level was especially evident in TNBC patient aged ≥50 years and body mass index (BMI) of ≥25 kg/m2. Relation between CYP 1A2 levels was the opposite. The rate of superoxide radicals’ production in both tumor tissue and tumor bordering adipose tissue was higher in TNBC patients. The correlation between high CYP 1B1 level together with the low level of CYP 1A2 and worse 5 years relapse-free survival in both TNBC and LABC patients was revealed. There was demonstrated a relation between increased urinary level of marker of oxidative DNA damage (8-OHdG) and overall survival of patients with BC. Conclusions: the spectrum and degree of changes in the levels of P-450 isoforms depend on the BC molecular subtype: levels of CYP 19A1 and CYP 1B1 are much higher, and level of CYP 1A2 is significantly lower in patients with TNBC compared to LABC patients. The level of cytochromes CYP 1A2 and CYP 1B1, patients’ body mass index and the duration of estrogen exposure can serve as possible predictors of unfavorable TNBC and LABC course.
References
Lefranc C, Friederich-Persson M, Palacios-Ramirez R, Aurelie Nguyen Dinh Cat. Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor. J Endocrinol 2018; 238 (3): R143–R159.
Horn J, Vatten L. Reproductive and hormonal risk factors of breast cancer: a historical perspective. Int J Women’s Health 2017; 2017 (9): 265–72.
Stocco C. Tissue physiology and pathology of aromatase. Steroids 2012; 77 (1–2): 27–35.
Belous AR, Hachey DL, Dawling Sh, et al. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res 2007; 67 (2): 812–7.
Kalyanaraman B, Sealy RC, Sivarajah K. An electron spin resonance study of o-semiquinones formed during the enzymatic and autoxidation of catechol estrogens. J Biol Chem 1984; 259: 14018–22.
Akanni A, Abul-Hajj YJ. Estrogen-nucleic acid adducts: dissection of the reaction of 3,4-estrone quinone and its radical anion and radical cation with deoxynucleosides and DNA. Chem Res Toxicol 1999; 12(12): 1247–53.
Embrechts J, Lemiere F, Van Dongen W, et al. Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. J Am Soc Mass Spectrom 2003; 14 (5): 482–91.
Burlaka AP, Motuzyuk IM, Sydorchuk OI, Virko SV. Cytochrome P-450, estrogen metabolites and superoxide radicals in breast cancer initiation and progression. Oncology 2020; 22(1–2): 42–6. in Ukrainian
Burlaka A, Rudiuk T, Burlaka A, Kolesnik O. 8-hydroxy-deoxyguanosine as an independent prognostic factor in patients with metastatic colorectal cancer. Archives Balkan Medical Union 2019; 54 (3): 445–54.
Cavalieri EL, Rogan EG. Role of aromatic hydrocarbons in disclosing how catecholestrogens initiate cancer. Adv Pharmacol 1998; 42: 837–40.
Loeb LA, Preston BD. Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 1986; 20: 201–30.
Hui Tian, Zhen Gao, Gang Wang, Huizhong Li, Jun Nian Zheng. Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation. Tumour Biol 2016; 37 (1): 141–50.
Okoh V. 4-hydroxy estradiol-induced oxidant-mediated signaling is involved in the development of breast cancer. FIU Electronic Theses and Dissertations. 2010. https://digitalcommons.fiu.edu/etd/348 DOI: 10.25148/etd.FI11041501
Burlaka АP, Virko SV, Burlaka AA, et al. Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer. Exp Oncol 2020; 42 (4): 330–2.
Burlaka AA, Vovk AV, Burlaka AP, Kolesnik OO. DNA oxidation in patients with metastastic colorectal cancer: clinical significance of 8-hydroxy-deoxyguanosine as an independent prognostic factor. Exp Oncol 2019; 41 (1): 26–31.
Sin-Aye Park. Catechol estrogen 4-hydroxyestradiol is an ultimate carcinogen in breast cancer. Biomed Sci Letters 2018; 24: 143–9.
Sateesh R, Aparna Rajeshwar Rao Bitla, Sandya Rani Budugu, et al. Oxidative stress in relation to obesity in breast cancer. Ind J Cancer 2019; 56 (1): 41–4.
